Personalized Medication for Pediatric and Geriatric Patients

Marked by creativity, accuracy, and empathy, personalized medicine acknowledges that every patient is different and that their health and response to therapy are influenced by a variety of genetic, environmental, and lifestyle factors. For pediatric and geriatric patients, who frequently appear with complicated and varied medical demands, this approach is especially important.This new volume, Personalized Medication for Pediatric and Geriatric Patients, explores the complexities and developments in modifying medical treatments to provide customized approaches to meet the special requirements of two of the most vulnerable demographics: seniors and children. The volume looks at personalized medication and treatment for young children and seniors for the treatment of cancer, respiratory diseases. gastrointestinal diseases, ocular diseases, endocrine disorders, hematological disorders, bacterial and fungal infections, vaccinations, and neurological disorders. The chapters demonstrates the progress made in treating disorders by taking into account the distinct physiological requirements and variances between individuals of different ages.The chapters also explore the use of biomarkers in personalized medication, the role of pharmacokinetics and pharmacodynamics in personalized medication, wearable healthcare technologies, the application of precision medicine techniques, and the impact of personalized medication on healthcare outcomes for seniors and children. The role of machine learning and artificial intelligence is also addressed along with how these cutting-edge tools are improving access to and accuracy of the treatment for these two populationsPersonalized Medication for Pediatric and Geriatric Patients provides a thorough understanding of the present and potential futures of personalized medicine for older and pediatric patients in order to improve their lives. This volume will be valuable for healthcare providers and medical professionals, healthcare researchers and scientists, healthcare policymakers and administrators, healthcare and medical faculty and students, and governments.